Updated on 2024/12/19

写真a

 
SHIMIZU Hideyuki
 
Organization
Nagoya University Hospital Ophthalmology Assistant professor of hospital
Title
Assistant professor of hospital

Degree 1

  1. 医学博士 ( 2020.3   名古屋大学 ) 

Research History 6

  1. Nagoya University   Nagoya University Hospital Ophthalmology   Assistant professor of hospital

    2024.4

  2. 聖隷浜松病院   眼形成眼窩外科   医長

    2022.4 - 2024.3

  3. Nagoya University   Assistant professor of hospital

    2020.7 - 2022.3

  4. 愛知県厚生農業協同組合連合会安城更生病院   眼科   医員

    2018.5 - 2020.6

  5. Nagoya University

    2016.4 - 2018.5

  6. 地域医療機能推進機構中京病院   初期研修医

    2014.4 - 2016.3

▼display all

Education 1

  1. Nagoya University

    2016.4 - 2020.3

Professional Memberships 9

  1. 日本眼形成再建外科学会

  2. 日本眼窩疾患シンポジウム

  3. 日本眼瞼義眼床手術学会

  4. 日本涙道・涙液学会

  5. 日本眼腫瘍学会

  6. 日本神経眼科学会

  7. 日本抗加齢医学会

  8. 日本網膜硝子体学会

  9. 日本眼科学会

▼display all

 

Papers 18

  1. Decrease in electrolyte after vitrectomy surgery may affect the results of forensic investigations using vitreous humor

    Ushida, H; Suzumura, A; Yamada, K; Shimizu, H; Suzuki, A; Ishikawa, Y; Kikuchi, R; Nishiguchi, KM; Kaneko, H

    BMC OPHTHALMOLOGY   Vol. 24 ( 1 )   2024.5

     More details

    Publisher:BMC Ophthalmology  

    Purpose: Vitreous humor (VH) is used for postmortem biochemical studies because it is well protected in an uncontaminated state even after death. The goal of this research was to investigate electrolyte concentrations in the VH from human eyes with and without a history of vitrectomy surgery. Methods: We analyzed the sodium (Na), potassium (K), chloride (Cl) and magnesium (Mg) concentrations from 34 VH samples from 34 patients. Eleven samples were from eyes with a history of vitrectomy, and the remaining 23 eyes had no history of vitrectomy. The correlations of Na, K, Cl and Mg concentrations with patient age, interval between first and second vitrectomy, and lens status (history of cataract surgery) were also evaluated. Results: The Na, K, Cl and Mg concentrations in VH from vitrectomized eyes were 134.1 ± 7.9 mmol/L, 3.7 ± 0.2 mmol/L, 99.7 ± 6.7 mmol/L and 0.59 ± 0.09 mmol/L, respectively; all were significantly lower than the corresponding concentrations in VH from control eyes (lower by 5.0%, 11.0%, 11.7%, and 22.6%, respectively). Na, K, Cl and Mg concentrations in VH from vitrectomized eyes did not show significant correlations with patient ages or the interval between their first and second vitrectomies. There were no significant differences in Na, K, Cl and Mg concentrations in VH between phakic eyes and intraocular lens-implanted eyes. Conclusions: With the increasing number of vitrectomies being performed, it is necessary to consider the history of vitrectomy when using a subject’s VH in forensic examination.

    DOI: 10.1186/s12886-024-03445-2

    Web of Science

    Scopus

    PubMed

  2. Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis

    Yamada, K; Tazaki, A; Ushio-Watanabe, N; Usui, Y; Takeda, A; Matsunaga, M; Suzumura, A; Shimizu, H; Zheng, H; Ariefta, NR; Yamamoto, M; Hara, H; Goto, H; Sonoda, KH; Nishiguchi, KM; Kato, M; Nishikawa, Y; Toyokuni, S; Kaneko, H

    REDOX BIOLOGY   Vol. 67   2023.11

     More details

    Publisher:Redox Biology  

    Toxoplasmosis is a major infectious disease, affecting approximately one-third of the world's population; its main clinical manifestation, ocular toxoplasmosis (OT), is a severe sight-threatening disease. Nevertheless, the diagnosis of OT is based on clinical findings, which needs improvement, even with biochemical tests, such as polymerase chain reaction and antibody detections. Furthermore, the efficacy of OT-targeted treatment is limited; thus, additional measures for diagnosis and treatments are needed. Here, we for the first time report a significantly reduced iron concentration in the vitreous humor (VH) of human patients infected with OT. To obtain further insights into molecular mechanisms, we established a mouse model of T. gondii infection, in which intravitreally injected tracer 57Fe, was accumulated in the neurosensory retina. T. gondii-infected eyes showed increased lipid peroxidation, reduction of glutathione peroxidase-4 expression and mitochondrial deformity in the photoreceptor as cristae loss. These findings strongly suggest the involvement of ferroptotic process in the photoreceptor of OT. In addition, deferiprone, an FDA-approved iron chelator, reduced the iron uptake but also ameliorated toxoplasma-induced retinochoroiditis by reducing retinal inflammation. In conclusion, the iron levels in the VH could serve as diagnostic markers and iron chelators as potential treatments for OT.

    DOI: 10.1016/j.redox.2023.102890

    Web of Science

    Scopus

    PubMed

  3. Dimethyl Fumarate Protects Retinal Pigment Epithelium from Blue Light-Induced Oxidative Damage via the Nrf2 Pathway

    Shimizu, H; Takayama, K; Yamada, K; Suzumura, A; Sato, T; Nishio, Y; Ito, M; Ushida, H; Nishiguchi, KM; Takeuchi, M; Kaneko, H

    ANTIOXIDANTS   Vol. 12 ( 1 )   2023.1

     More details

    Language:English   Publisher:Antioxidants  

    The purpose of this study is to investigate the protective effect of dimethyl fumarate (DMF), the methyl-ester of fumaric acid, against blue-light (BL) exposure in retinal pigment epithelial (RPE) cells. ARPE-19 cells, a human RPE cell line, were cultured with DMF followed by exposure to BL. Reactive oxygen species (ROS) generation, cell viability, and cell death rate were determined. Real-time polymerase chain reaction and Western blotting were performed to determine the change in nuclear factor (erythroid-derived)-like 2 (NRF2) expression. Twenty-seven inflammatory cytokines in the supernatant of culture medium were measured. BL exposure induced ROS generation in ARPE-19 cells, which DMF alleviated in a concentration-dependent manner. BL exposure increased the ARPE-19 cell death rate, which DMF alleviated. BL exposure induced ARPE-19 cell apoptosis, again alleviated by DMF. Under BL exposure, DMF increased the NRF2 mRNA level and promoted NRF2 expression in the nucleus. BL also strongly increased interleukin (IL)-1β and fibroblast growth factor (FGF) expression. BL strongly induced RPE cell damage with apoptotic change while DMF mainly reduced inflammation in BL-induced RPE damage, resulting in blockade of cell death. DMF has a protective effect in RPE cells against BL exposure via activation of the NRF2 pathway.

    DOI: 10.3390/antiox12010045

    Web of Science

    Scopus

    PubMed

  4. INTRAOPERATIVE AND POSTOPERATIVE MONITORING OF AUTOLOGOUS NEUROSENSORY RETINAL FLAP TRANSPLANTATION FOR A REFRACTORY MACULAR HOLE ASSOCIATED WITH HIGH MYOPIA

    Takeuchi, J; Kataoka, K; Shimizu, H; Tomita, R; Kominami, T; Ushida, H; Kaneko, H; Ito, Y; Terasaki, H

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES   Vol. 41 ( 5 ) page: 921 - 930   2021.5

     More details

    Language:English   Publisher:Retina  

    Purpose:To describe the intraoperative and postoperative morphological and functional outcomes after autologous neurosensory retinal flap transplantation (ART) for a high myopia-related refractory macular hole (MH).Methods:This prospective interventional study enrolled five eyes of five patients (age range 54-84 years) with highly myopic refractory MHs who underwent ART. All cases were evaluated with intraoperative optical coherence tomography and postoperative optical coherence tomography, optical coherence tomography angiography, and microperimetry for at least 6 months postoperatively.Results:Intraoperatively, the MH was covered by an ART flap with a persistent small subretinal space that was filled with the ART flap after 4 days to 6 days. Optical coherence tomography discriminated the original from the transplanted retina. The mean basal diameter of the original MH decreased from 1,504 ± 684 µm preoperatively to 1,111 ± 356 µm postoperatively. The best-corrected visual acuity improved in two cases, was stable in two cases, and deteriorated in one case. Microperimetry demonstrated no obvious postoperative changes in the fixation points and the absolute scotoma corresponding to the base of MHs with chorioretinal atrophy. In two eyes, choroidal neovascularization developed beneath the transplanted retinas.Conclusion:Transplanted tissue was in a fixed position by 1 week postoperatively with a decreased diameter of the original MH. Postoperative fixation points were on the original retina at the MH edge. Because choroidal neovascularization may develop, detailed monitoring is required.

    DOI: 10.1097/IAE.0000000000003000

    Web of Science

    Scopus

    PubMed

  5. Effect of internal limiting membrane peeling on visual field sensitivity in eyes with epiretinal membrane accompanied by glaucoma with hemifield defect and myopia

    Kaneko, H; Hirata, N; Shimizu, H; Kataoka, K; Nonobe, N; Mokuno, K; Terasaki, H

    JAPANESE JOURNAL OF OPHTHALMOLOGY   Vol. 65 ( 3 ) page: 380 - 387   2021.5

     More details

    Language:English   Publisher:Japanese Journal of Ophthalmology  

    Purpose: To investigate the effects of internal limiting membrane (ILM) peeling on visual field sensitivities in eyes with epiretinal membrane (ERM) accompanied by glaucoma with hemifield defect and myopia. Study design: Retrospective clinical study Methods: We reviewed clinical records of patients with ERM who underwent vitrectomy and ERM/ILM peeling. We first collected clinical data of eyes with ERM and glaucoma with hemifield defect. We recorded visual field sensitivities at 52 points and analyzed differences between before and after surgery. We then compared the changes in visual field sensitivity between glaucomatous and normal hemifields. Next, we collected ERM eyes without glaucoma and stratified them into two groups based on axial length (threshold = 26.0 mm). In these eyes, we also recorded visual field sensitivities at 52 points and analyzed differences between before and after surgery. Results: The study included 18 eyes with ERM and glaucoma with hemifield defect (11 men; mean age, 68.3 ± 7.2 years). These eyes showed significant sensitivity reductions at 5/26 points, mainly in the nasal area of the glaucomatous hemifield, whereas only 1/26 points exhibited significant sensitivity reduction in the normal hemifield. In eyes with axial length <26.0 mm and axial length ≥26.0 mm, 29 peripheral and seven superior peripheral points showed significant improvements in visual field sensitivities, respectively. Conclusion: Visual field sensitivity reduction occurred mainly in the nasal region of the glaucomatous hemifield. Differences in axial length alone were not a prominent risk factor for reduced visual field sensitivity after ILM peeling in eyes with ERM.

    DOI: 10.1007/s10384-021-00817-9

    Web of Science

    Scopus

    PubMed

  6. Caveolin-1 Promotes Cellular Senescence in Exchange for Blocking Subretinal Fibrosis in Age-Related Macular Degeneration

    Shimizu Hideyuki, Yamada Kazuhisa, Suzumura Ayana, Kataoka Keiko, Takayama Kei, Sugimoto Masataka, Terasaki Hiroko, Kaneko Hiroki

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   Vol. 61 ( 11 ) page: 21   2020.9

     More details

    Publisher:Investigative Ophthalmology and Visual Science  

    DOI: 10.1167/iovs.61.11.21

    Web of Science

    Scopus

    PubMed

  7. Lamivudine Inhibits Alu RNA-induced Retinal Pigment Epithelium Degeneration via Anti-inflammatory and Anti-senescence Activities

    Yamada Kazuhisa, Kaneko Hiroki, Shimizu Hideyuki, Suzumura Ayana, Namba Rina, Takayama Kei, Ito Seina, Sugimoto Masataka, Terasaki Hiroko

    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY   Vol. 9 ( 8 ) page: 1 - 10   2020.7

     More details

    Publisher:Translational Vision Science and Technology  

    DOI: 10.1167/tvst.9.8.1

    Web of Science

    Scopus

    PubMed

  8. n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Muller BDNF in Diabetic Retinopathy

    Suzumura Ayana, Kaneko Hiroki, Funahashi Yasuhito, Takayama Kei, Nagaya Masatoshi, Ito Seina, Okuno Toshiaki, Hirakata Toshiaki, Nonobe Norie, Kataoka Keiko, Shimizu Hideyuki, Namba Rina, Yamada Kazuhisa, Ye Fuxiang, Ozawa Yoko, Yokomizo Takehiko, Terasaki Hiroko

    DIABETES   Vol. 69 ( 4 ) page: 724 - 735   2020.4

     More details

  9. Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration

    Matsuura Toshiyuki, Kaneko Hiroki, Takayama Kei, Shibata Rei, Kataoka Keiko, Ito Seina, Tsunekawa Taichi, Shimizu Hideyuki, Suzumura Ayana, Namba Rina, Ito Yasuki, Murohara Toyoaki, Terasaki Hiroko

    BMC OPHTHALMOLOGY   Vol. 20 ( 1 ) page: 56   2020.2

     More details

  10. Silicone oil-associated retinal light exposure under a surgical microscope

    Yamada Kazuhisa, Kaneko Hiroki, Tsunekawa Taichi, Shimizu Hideyuki, Suzumura Ayana, Namba Rina, Takeuchi Jun, Kataoka Keiko, Takayama Kei, Inoue Makoto, Ito Yasuki, Terasaki Hiroko

    ACTA OPHTHALMOLOGICA   Vol. 97 ( 5 ) page: E742 - E746   2019.8

     More details

    Publisher:Acta Ophthalmologica  

    DOI: 10.1111/aos.14038

    Web of Science

    Scopus

    PubMed

  11. In Vitro Epiretinal Membrane Model and Antibody Permeability: Relationship With Anti-VEGF Resistance in Diabetic Macular Edema

    Namba Rina, Kaneko Hiroki, Suzumura Ayana, Shimizu Hideyuki, Kataoka Keiko, Takayama Kei, Yamada Kazuhisa, Funahashi Yasuhito, Ito Seina, Nonobe Norie, Terasaki Hiroko

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   Vol. 60 ( 8 ) page: 2942 - 2949   2019.7

     More details

    Publisher:Investigative Ophthalmology and Visual Science  

    DOI: 10.1167/iovs.19-26788

    Web of Science

    Scopus

    PubMed

  12. Vascular maturity of type 1 and type 2 choroidal neovascularization evaluated by optical coherence tomography angiography

    Nakano Yuyako, Kataoka Keiko, Takeuchi Jun, Fujita Ai, Kaneko Hiroki, Shimizu Hideyuki, Ito Yasuki, Terasaki Hiroko

    PLOS ONE   Vol. 14 ( 4 ) page: e0216304   2019.4

     More details

  13. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEAL AVASCULAR ZONE IN CHILDREN WITH A HISTORY OF TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY

    Nonobe Norie, Kaneko Hiroki, Ito Yasuki, Takayama Kei, Kataoka Keiko, Tsunekawa Taichi, Matsuura Toshiyuki, Suzumura Ayana, Shimizu Hideyuki, Terasaki Hiroko

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES   Vol. 39 ( 1 ) page: 111 - 117   2019.1

     More details

  14. Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors

    Shimizu Hideyuki, Kaneko Hiroki, Suzumura Ayana, Takayama Kei, Namba Rina, Funahashi Yasuhito, Kataoka Keiko, Iwase Takeshi, Hwang Shiang-Jyi, Ito Seina, Yamada Kazuhisa, Ueno Shinji, Ito Yasuki, Terasaki Hiroko

    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY   Vol. 8 ( 1 ) page: 28   2019.1

     More details

    Publisher:Translational Vision Science and Technology  

    DOI: 10.1167/tvst.8.1.28

    Web of Science

    Scopus

    PubMed

  15. Novel Classification of Early-stage Systemic Hypertensive Changes in Human Retina Based on OCTA Measurement of Choriocapillaris

    Takayama Kei, Kaneko Hiroki, Ito Yasuki, Kataoka Keiko, Iwase Takeshi, Yasuma Tetsuhiro, Matsuura Toshiyuki, Tsunekawa Taichi, Shimizu Hideyuki, Suzumura Ayana, Ra Eimei, Akahori Tomohiko, Terasaki Hiroko

    SCIENTIFIC REPORTS   Vol. 8 ( 1 ) page: 15163   2018.10

     More details

  16. Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases

    Kaneko Hiroki, Takayama Kei, Asami Tetsu, Ito Yasuki, Tsunekawa Taichi, Iwase Takeshi, Funahashi Yasuhito, Ueno Shinji, Nonobe Norie, Yasuda Shunsuke, Suzumura Ayana, Shimizu Hideyuki, Kimoto Reona, Hwang Shiang-Jyi, Terasaki Hiroko

    SCIENTIFIC REPORTS   Vol. 7 ( 1 ) page: 2640   2017.5

     More details

  17. Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy

    Nagasaka Yosuke, Kaneko Hiroki, Ye Fuxiang, Kachi Shu, Asami Tetsu, Kato Seiichi, Takayama Kei, Hwang Shiang-Jyi, Kataoka Keiko, Shimizu Hideyuki, Iwase Takeshi, Funahashi Yasuhito, Higuchi Akiko, Senga Takeshi, Terasaki Hiroko

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   Vol. 58 ( 1 ) page: 221 - 229   2017.1

     More details

    Publisher:Investigative Ophthalmology and Visual Science  

    DOI: 10.1167/iovs.16-20513

    Web of Science

    Scopus

    PubMed

  18. Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal Detachment

    Tsunekawa Taichi, Kaneko Hiroki, Takayama Kei, Hwang Shiang-Jyi, Oishi Akio, Nagasaka Yosuke, Ye Fuxiang, Iwase Takeshi, Nonobe Norie, Ueno Shinji, Ito Yasuki, Yasuda Shunsuke, Matsuura Toshiyuki, Shimizu Hideyuki, Suzumura Ayana, Kataoka Keiko, Terasaki Hiroko

    BIOMED RESEARCH INTERNATIONAL   Vol. 2017   page: 3427319   2017

     More details

    Publisher:BioMed Research International  

    DOI: 10.1155/2017/3427319

    Web of Science

    Scopus

    PubMed

▼display all

Books 8

  1. あたらしい眼科 Vol.41 No.12

    ( Role: Contributor ,  これで盤石!眼窩疾患の診かた-眼窩の解剖-)

    メディカル葵出版  2024.12 

  2. 眼科レジデントのためのベーシック手術 第2版

    ( Role: Contributor ,  眼瞼裂傷・涙小管断裂縫合術)

    日本医事新報社  2024.11 

  3. 動画で学ぶ 眼科処置・小手術の実際

    ( Role: Contributor ,  3.1 眼瞼の麻酔 4.4 涙道内視鏡併用涙管チューブ挿入術 )

    中山書店  2024.11 

  4. 眼科の検査機器・手術器具パーフェクトブック

    ( Role: Contributor ,  眼窩腫瘍摘出術・眼窩吹き抜け骨折の手術)

    MCメディカ出版  2024.10 

  5. 週刊日本医事新報

    ( Role: Contributor ,  私の治療 眼窩骨折(眼窩ブローアウト骨折))

    日本医事新報社  2024.4 

  6. 眼科の処置・小手術・最新の治療 基本手技から緊急時の対応まで

    ( Role: Contributor ,  眼瞼への麻酔・切開・縫合)

    医学書院  2023.10 

  7. 外来処置・小手術で求められる手技のコツとこだわり

    ( Role: Contributor ,  眼帯(眼瞼手術後)の正しい付け方)

    MCメディカ出版  2023.10 

  8. あたらしい眼科Vol.38 No.04

    ( Role: Contributor ,  基礎研究コラム:線維化と細胞老化)

    メディカル葵出版  2021.4 

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 2

  1. 細胞老化と脂肪変性・線維化に着目した後天性眼瞼下垂の原因別病態解明

    Grant number:22K16968  2022.4 - 2025.3

    科学研究費助成事業  若手研究

    清水 英幸

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    後天性眼瞼下垂は非常に患者数の多い疾患であるが、現在予防法はなく治療法は手術のみである。本研究の目的は後天性眼瞼下垂の手術際切除した組織を免疫染色、遺伝子、タンパク質発現解析することで生化学的なアプローチから病態を解明し、新たな治療法や予防法の開発に繋げることである。
    本研究では、手術以外に治療法のない後天性眼瞼下垂症の病態を明らかにすることで、最終的には後天性眼瞼下垂症の新たな治療法の糸口を見つけることを目的としている。後天性眼瞼下垂症の原因は加齢、ハードコンタクトレンズの長期装用や緑内障の治療点眼薬によるものなどがあるが、組織学的な病態変化が異なる。原因の違いにより、眼瞼挙筋群の筋肉や腱膜が脂肪変性や線維化を生じて脆弱化することがわかっている。
    様々な原因により後天性眼瞼下垂症となった症例の手術の際に組織を採取して各種の分析を行うことで、原因ごとの特徴をつかむことがまず目標となる。
    眼瞼下垂症の手術術式は様々であるが、その中でも挙筋短縮術が一番治療効果がある。
    この術式では挙筋群を丸ごと前転して眼窩隔膜の翻転部を瞼板の上端に戻すことで解剖学的に生理的な位置に戻すことが出来る。生理的な位置に戻した後、瞼板より前方の組織は機能的に不要であり、この部分を切除することで挙筋群を解析するのに十分な量切除できることがわかった。今後この術式を用いて様々な症例の組織を採取していく予定である。
    また、採取した挙筋群を固定、染色し、組織学的に構造が壊れず評価できる方法も確立した。当初は挙筋群のみを評価する予定であったが、症例によっては眼窩隔膜と挙筋群の間にある脂肪を切除する場合もあり、切除した脂肪も評価することにした。今後評価する組織の種類が更に増える可能性がある。
    これらの結果は、順次学会で報告し、論文として投稿する予定である。
    本研究を遂行するには、後天性眼瞼下垂症手術の際に採取した組織が必要である。
    しかし新型コロナウイルス感染症の感染拡大により、緊急性のない眼瞼下垂症手術は軒並み延期となり、十分な数の組織が採取できなかった。
    2023年度は眼瞼下垂症の手術も制限がなくなるため、組織の採取も問題なく出来ると考えられる。
    採取した眼瞼の組織を免疫染色・特殊染色を行う。また遺伝子発現分析、たんぱく質発現分析も行う。これらにより眼瞼の細胞老化や線維化の程度を多角的に評価する。
    その後眼瞼下垂の重症度・術後成績と細胞老化・脂肪変性・線維化の関連分析、眼瞼下垂の重症度・術後成績とプロスタグランジン系点眼薬の種類、使用歴との因果関係分析、眼瞼下垂と全身疾患との因果関係分析を行う。

  2. The development of novel VEGF non-dependent therapy for the refractory retinal diseases

    Grant number:17K16963  2017.4 - 2019.3

    Kaneko Hiroki

      More details

    Authorship:Other 

    Caveolin-1 was enhanced in the proliferation membrane of patients with proliferative vitreoretinopathy, and we confirmed similar changes in the mouse eye. Caveolin-1 was expressed in proliferating tissue has an effect of suppressing epithelial-mesenchymal transition of retinal pigment epithelial cells. Attenuation of the oscillatory potential (OP) wave of the electroretinogram (ERG) was confirmed in diabetic model rats and it was improved by oral administration of eicosapentaenoic acid (EPA). In addition, brain-derived trophic factor (BDNF) in Muller cells was elevated by EPA intake. In studies of age-related macular degeneration, Alu was administered into human RPE cells and in the eye of mice to confirm elevation of IL1β and IL18 and the reverse transcriptase inhibitor Lamivudine suppressed the increase of IL1β and IL18.